from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2512c/-

LFCtreatmentdescriptionclass of inhibitor

-0.336

Amikacinug/mL Amikacintranslation

0.112

Cap5-10ug/mL Capreomycintranslation

1.128

Rox10-50 ug/mL Roxithromycintranslation

-0.138

SM2-5 ug/mL Streptomycintranslation

1.335

Tet5-10 ug/mL Tetracyclinetranslation

-0.046

Rif0.2-5ug/mL Rifampicintranscription

-1.181

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.877

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.466

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.417

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.936

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.634

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

3.169

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.109

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.423

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.871

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.866

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.213

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.906

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.072

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.005

KCN5-20 ug/mL Potassium cyaniderespiration

-0.124

NaN30.2-2 mM Sodium aziderespiration

0.204

Nigericin50 uM Nigericinrespiration

0.287

TRC10-150 ug/mL Triclosanrespiration

-0.414

TRZ10-25 ug/mL Thioridazinerespiration

0.481

Valinomycin0.5-10 uM Valinomycinrespiration

-0.871

ZnSO42 mM ZnSO4respiration

-0.347

menadione6-10 ug/mL Menadionerespiration

-0.055

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.138

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.032

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.165

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.149

NRP_1Non-replicating persistence stage 1dosRassociated

0.635

Amp0.2mg/mL AmpicillincellWall

0.242

Cephalexin20-100 ug/mL CephalexincellWall

0.335

Cerulenin0.32-5 ug/mL CerulenincellWall

0.132

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.755

EMB10-20 ug/mL EthambutolcellWall

-0.163

Eta12-40 ug/mL EthionamidecellWall

-0.308

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.128

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.584

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.043

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.301

BZA0.12 mg/mL BenzamidearomaticAmides

-0.038

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.147

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.197

H2O24 mM hydrogen peroxideDNAdamaging

0.992

Levo10 ug/mL LevofloxacinDNAdamaging

-0.335

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.707

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.914

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.825

UVUV-irradiationDNAdamaging

0.164

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.621

Antimycin12.5-50 ug/mL Antimycin A?

0.204

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.267

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.652

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.884

PA8240.2-2 ug/mL PA-824?

1.978

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.012

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.267

Verapamil50 uM Verapamil?

0.068

mercaptoethanol2 mM 2-Mercaptoethanol?

0.732

methoxatin10-20 ug/mL Methoxatin?